NeuroOne Medical Technologies Corporation announced the appointment of Vanessa Tolosa to its Scientific Advisory Board. Tolosa, one of the founding members of Neuralink Corp., a company started by Elon Musk to build a complete Brain-Machine Interface, brings specialized expertise that the company believes will help expedite its further development of thin-film electrodes that provide long-term stimulation for treatment of neurological applications, such as epilepsy, Parkinson’s disease, failed back surgery syndrome and other neurological applications that may benefit from high-density thin film electrode technology. Most recently at Neuralink, Tolosa worked to develop a Brain Machine Interface for medical use and beyond. As director of neural interfaces, she directed the design, prototyping, development and testing of technologies related to implantable microelectrodes, electronics micro-assembly and hermetic packaging. Previously, at Lawrence Livermore National Laboratories (LLNL), Tolosa led all implantable neurotechnology efforts, including high-density electrode technology.